Presentation Information
[O7-02]Modulating immunogenicity and reactogenicity in mRNA-lipid nanoparticle vaccines through lipid component optimization
*Yasuo Yoshioka1,2,3,4,5 (1. Center for Advanced Modalities and DDS, The University of Osaka (Japan), 2. Research Institute for Microbial Disease, The University of Osaka (Japan), 3. Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka (Japan), 4. Graduate School of Pharmaceutical Sciences, The University of Osaka (Japan), 5. The Research Foundation for Microbial Diseases of Osaka University (Japan))

Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in
